Concepedia

Author

Sith Sathornsumetee

Duke Medical CenterORCID

Also Known As

S Sathornsumetee, S. Sathornsumetee, Sahtornsumetee, S., Sith Sathornsumetee, Sith Sathornsumetee

132

Publications

10.7K

Citations

35

H-Index

69

Concepts

All Affiliations

Duke Medical CenterDuke University HospitalMahidol UniversitySiriraj HospitalDuke University
SS

About

Sith Sathornsumetee is an author at Duke Medical Center specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

31

5.3K

2

Health Sciences

9

9

1.9K

3

Engineering

2

2

30

4

Social Sciences

1

1

20

5

Applied Physiology

1

1

21

Sith Sathornsumetee

×

50

Publications

9.6K

Citations

29

H-Index

YearCitations

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins, James E. Herndon,

Journal of Clinical Oncology

2007

1.4K

Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor

Shideng Bao, Qiulian Wu, Sith Sathornsumetee,

Cancer Research

2006

1.3K

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

Zhizhong Li, Shideng Bao, Qiulian Wu,

Cancer Cell

2009

1.3K

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

James J. Vredenburgh, Annick Desjardins, James E. Herndon,

Clinical Cancer Research

2007

1.1K

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran,

The Lancet Oncology

2017

1.1K

Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth

Shideng Bao, Qiulian Wu, Zhizhong Li,

Cancer Research

2008

416

Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme

David A. Reardon, Merrill J. Egorin, Jennifer A. Quinn,

Journal of Clinical Oncology

2005

330

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

Sith Sathornsumetee, Yiting Cao, Jennifer Marcello,

Journal of Clinical Oncology

2008

260

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh,

Neuro-Oncology

2010

226

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

David A. Reardon, Annick Desjardins, James J. Vredenburgh,

British Journal of Cancer

2009

208

Page 1